Warwick, Alasdair N.
Curran, Katie
Hamill, Barbra
Stuart, Kelsey http://orcid.org/0000-0001-7353-8774
Khawaja, Anthony P. http://orcid.org/0000-0001-6802-8585
Foster, Paul J. http://orcid.org/0000-0002-4755-177X
Lotery, Andrew J. http://orcid.org/0000-0001-5541-4305
Quinn, Michael
Madhusudhan, Savita
Balaskas, Konstantinos
Peto, Tunde http://orcid.org/0000-0001-6265-0381
Allen, N.
Aslam, T.
Atan, D.
Barman, S.
Barrett, J.
Bishop, P.
Black, G.
Braithwaite, T.
Carare, R.
Chakravarthy, U.
Chan, M.
Chua, S.
Day, A.
Desai, P.
Dhillon, B.
Dick, A.
Doney, A.
Egan, C.
Ennis, S.
Foster, P.
Fruttiger, M.
Gallacher, J.
Garway-Heath, D.
Gibson, J.
Guggenheim, J.
Hammond, C.
Hardcastle, A.
Harding, S.
Hogg, R.
Hysi, P.
Keane, P.
Khaw, P. T.
Khawaja, A.
Lascaratos, G.
Littlejohns, T.
Lotery, A.
Luthert, P.
Macgillivray, T.
Mackie, S.
Mcguinness, B.
Mckay, G.
Mckibbin, M.
Moore, T.
Morgan, J.
Oram, R.
O’sullivan, E.
Owen, C.
Patel, P.
Paterson, E.
Peto, T.
Petzold, A.
Pontikos, N.
Rahi, J.
Rudnicka, A.
Sattar, N.
Self, J.
Sergouniotis, P.
Sivaprasad, S.
Steel, D.
Stratton, I.
Strouthidis, N.
Sudlow, C.
Sun, Z.
Tapp, R.
Thomas, D.
Trucco, E.
Tufail, A.
Viswanathan, A.
Vitart, V.
Weedon, M.
Williams, K.
Williams, C.
Woodside, J.
Yates, M.
Yip, J.
Zheng, Y.
,
Funding for this research was provided by:
Fight for Sight UK (1507 & 1508, 1507 & 1508, 1507 & 1508, 1507 & 1508, 1507 & 1508, 1507 & 1508, 1507 & 1508, 1507 & 1508, 1507 & 1508, 1507 & 1508, 1507 & 1508)
Moorfields Eye Charity (Previous Moorfields Special Trustees ref: ST 15 11 E) The Macular Society (London) - No award/grant number
Article History
Received: 14 May 2022
Revised: 26 September 2022
Accepted: 18 October 2022
First Online: 3 November 2022
Change Date: 5 January 2023
Change Type: Correction
Change Details: A Correction to this paper has been published:
Change Details: https://doi.org/10.1038/s41433-022-02377-9
Competing interests
: ANW, KC, BH, KS, AJL, PJF, MQ and SM declare no competing interests. AC’s financial interests: Consultant/Contractor (Aerie, Google Health, Novartis, Reichert, Santen, Thea, Abbvie). KB’s financial interests: Consultant/Contractor (Roche, Novartis); Financial support (Roche, Novartis, Bayer, Apellis); Recipient: (Novartis, Bayer, Roche, Alimera, Heidelberg Engineering). TP’s financial interests: Consultant/Contractor (Optos and Optomed); Recipient (Allergan, Genentech/Roche, Oxurion, Novartis, Bayer, Heidelberg, Optos, Apellis, Alimera, Bayer). APK has acted as a consultant to Abbvie, Aerie, Google Health, Novartis, Reichert, Santen and Thea.